William Blair initiated coverage on Brickell Biotech
$BBI
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
William Blair initiated coverage of Brickell Biotech with a rating of Outperform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/8/2022 | Outperform | William Blair | |
| 1/18/2022 | $2.00 | Buy | HC Wainwright & Co. |